A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
79 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigational Site Number : 0320005
Berazategui, Buenos Aires, Argentina
Recruiting - Investigational Site Number : 0320003
San Isidro, Buenos Aires, Argentina
Recruiting - Investigational Site Number : 0320002
Resistencia, Chaco Province, Argentina
Recruiting - Investigational Site Number : 0320004
Buenos Aires, Argentina
Recruiting
- Investigational Site Number : 0560001
Leuven, Belgium
Recruiting
- Investigational Site Number : 1240001
Sherbrooke, Quebec, Canada
Recruiting
- Investigational Site Number : 1520005
Concepción, Biobio, Chile
Recruiting - Centro de Estudios G Y C-Site Number : 1520003
Santiago, Reg Metropolitana de Santiago, Chile
Iván GónzalezRecruiting - Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, Chile
Recruiting - Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, Chile
Recruiting - Investigational Site Number : 1520006
Santiago, Reg Metropolitana de Santiago, Chile
Recruiting
- Investigational Site Number : 1560001
Beijing, China
Recruiting - Investigational Site Number : 1560004
Beijing, China
Recruiting - Investigational Site Number : 1560008
Beijing, China
Recruiting - Investigational Site Number : 1560012
Chengdu, China
Recruiting - Investigational Site Number : 1560010
Hangzhou, China
Recruiting - Investigational Site Number : 1560003
Jiazhuang, China
Recruiting - Investigational Site Number : 1560005
Taiyuan, China
Recruiting - Investigational Site Number : 1560013
Taiyuan, China
Recruiting - Investigational Site Number : 1560011
Wuhan, China
Recruiting - Investigational Site Number : 1560009
Yantai, China
Recruiting
- Ap-Hp - Hôpital Beaujon-Site Number : 2500002
Clichy, France
Active, not recruiting - Investigational Site Number : 2500001
Marseille, France
Recruiting - Chu Bordeaux - Hôpital Haut Leveque-Site Number : 2500003
Pessac, France
Active, not recruiting
- Investigational Site Number : 2760001
Berlin, Germany
Recruiting - Investigational Site Number : 2760003
Erlangen, Germany
Recruiting - Investigational Site Number : 2760004
Minden, Germany
Recruiting - Investigational Site Number : 2760006
Ulm, Germany
Recruiting
- Rabin Mc, Outpatient Clinics Building-Site Number : 3760001
Petah Tikva, Central District, Israel
Elisheva Pokroy ShapiraRecruiting - Sourasky Rheumatology Dept, Rishonim Building-Site Number : 3760005
Tel Aviv, Central District, Israel
Yael Lahat GoldsteinRecruiting
- Aou Meyer Irccs-Site Number : 3800003
Florence, Firenze, Italy
Prof. Augusto VaglioRecruiting - Irccs Ospedale San Raffaele-Site Number : 3800001
Milan, Lombardy, Italy
Prof. Lorenzo DagnaRecruiting - Centro Ricerche Cliniche Di Verona S.R.L. C/o Policlinico G.B.Rossi-Site Number : 3800002
Verona, Veneto, Italy
Prof. Luca FrulloniRecruiting
- Investigational Site Number : 3920004
Kitakyushu, Fukuoka, Japan
Recruiting - Hiroshima University Hospital-Site Number : 3920007
Hiroshima, Hiroshima, Japan
Shintaro HirataRecruiting - Investigational Site Number : 3920011
Sapporo, Hokkaido, Japan
Recruiting - Kobe University Hospital-Site Number : 3920010
Kobe, Hyōgo, Japan
Yuzo KodamaRecruiting - Kanazawa Medical University Hospital-Site Number : 3920002
Kahoku, Uchinada, Ishikawa-ken, Japan
Yasufumi MasakiRecruiting - Investigational Site Number : 3920001
Kanazawa, Ishikawa-ken, Japan
Recruiting - Investigational Site Number : 3920005
Nagaoka, Niigata, Japan
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2025
- Primary completion
- 28 Jun 2028
- Completion
- 25 Dec 2030
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 124
- Registry id
- NCT07190196
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.